Bio-reference Labs, Inc. (BRLI) Tops Q4 EPS by 2c

December 8, 2011 8:34 AM EST
Bio-reference Labs, Inc. (NASDAQ: BRLI) reported Q4 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $151.3 million versus the consensus estimate of $150.46 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings